The Use of Mass Spectrometry to Examine IDPs: Unique Insights and Caveats. (2018)
Attributed to:
Developing a new class of anti-amyloid experimental therapeutics in diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/bs.mie.2018.09.038
PubMed Identifier: 30471696
Publication URI: http://europepmc.org/abstract/MED/30471696
Type: Journal Article/Review
Volume: 611
Parent Publication: Methods in enzymology
ISSN: 0076-6879